Biomarin   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: San Rafael CA United States (2003)

Organization Overview

First Clinical Trial
2003
NCT00048620
First Marketed Drug
2003
laronidase (aldurazyme)
First NDA Approval
2003
laronidase (aldurazyme)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BIOMARIN | BIOMARIN PHARM | BioMarin Pharmaceutical | BioMarin Pharmceutical Inc.